Quarterly Consolidated Statement Of Cash Flows

KYORIN Pharmaceutical Co., Ltd. - Filing #7330327

Concept 2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
7,019,000,000 JPY
55,016,000,000 JPY
2,974,000,000 JPY
6,906,000,000 JPY
Depreciation
4,290,000,000 JPY
3,840,000,000 JPY
Impairment losses
JPY
257,000,000 JPY
Increase (decrease) in allowance for doubtful accounts
5,000,000 JPY
-6,000,000 JPY
Interest and dividend income
-501,000,000 JPY
-465,000,000 JPY
Interest expenses
66,000,000 JPY
66,000,000 JPY
Share of loss (profit) of entities accounted for using equity method
12,000,000 JPY
0 JPY
Decrease (increase) in trade receivables
-439,000,000 JPY
-5,621,000,000 JPY
Decrease (increase) in inventories
-5,444,000,000 JPY
-5,809,000,000 JPY
Increase (decrease) in trade payables
502,000,000 JPY
2,866,000,000 JPY
Other, net
-62,000,000 JPY
-973,000,000 JPY
Subtotal
4,695,000,000 JPY
216,000,000 JPY
Interest and dividends received
501,000,000 JPY
473,000,000 JPY
Interest paid
-66,000,000 JPY
-66,000,000 JPY
Income taxes paid
-2,975,000,000 JPY
-2,065,000,000 JPY
Net cash provided by (used in) operating activities
1,549,000,000 JPY
2,008,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-5,778,000,000 JPY
-6,330,000,000 JPY
Proceeds from sale of property, plant and equipment
0 JPY
100,000,000 JPY
Purchase of investment securities
0 JPY
-100,000,000 JPY
Other, net
-509,000,000 JPY
-251,000,000 JPY
Net cash provided by (used in) investing activities
-3,187,000,000 JPY
-6,275,000,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-200,000,000 JPY
-200,000,000 JPY
Dividends paid
-3,013,000,000 JPY
-3,015,000,000 JPY
Net cash provided by (used in) financing activities
-3,347,000,000 JPY
-3,363,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
87,000,000 JPY
241,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-4,897,000,000 JPY
-7,388,000,000 JPY
Cash and cash equivalents
13,886,000,000 JPY
18,816,000,000 JPY
26,289,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.